Jaleco A C, Covas M J, Pinto L A, Victorino R M
Department of Medicine 2/Clinical Immunology, Faculty of Medicine of Lisbon, Santa Maria Hospital, Portugal.
AIDS. 1994 Dec;8(12):1663-8. doi: 10.1097/00002030-199412000-00004.
Some clinical studies indicate that disease progression in HIV-2-infected subjects may be slower than in HIV-1. We investigated whether there were differences in the distribution of CD45RO+ (memory) and CD45RA+ (naive) T-cell subsets between HIV-1 and HIV-2 infection.
Analysis of lymphocyte subsets was performed by flow cytometry in peripheral blood mononuclear cells from healthy controls, HIV-1-(n = 49) and HIV-2-infected (n = 47) individuals divided into two groups: asymptomatic (ASY)/persistent generalized lymphadenopathy (PGL) and AIDS-related complex (ARC)/AIDS.
Both HIV-1- and HIV-2-infected patients had significant reductions in the absolute number and percentage of CD4+ lymphocytes compared with seronegative individuals. No significant differences were found between HIV-2- and HIV-1-infected subjects in the same clinical stage. CD4+CD45RA+ cells were significantly reduced in HIV-1 and HIV-2 ARC/AIDS patients and mildly reduced in ASY/PGL HIV-1 and HIV-2 patients. There were no differences in the degree of reduction of CD4+CD45RO+ cells in ASY/PGL HIV-1 versus HIV-2 patients. However, in HIV-1-infected ARC/AIDS individuals the reduction in the percentage of this subset was more pronounced than in HIV-2 infection and this difference reached statistical significance. The increase in CD8+ lymphocytes (percentage and absolute number) was more pronounced in HIV-1 and the differences between HIV-1- and HIV-2-infected patients were statistically significant. CD8+CD45RO+ cells were significantly increased both in ASY/PGL and ARC/AIDS HIV-1-infected patients, whereas HIV-2-infected ASY/PGL patients had normal levels of these cells and HIV-2-infected ARC/AIDS patients had increases that were much less pronounced than that observed in HIV-1-infected ARC/AIDS patients. Significant differences in the absolute number and percentage of this subset between HIV-1- and HIV-2-infected individuals in similar clinical stages were found.
HIV-2-infected individuals exhibit a lesser degree of depletion of memory CD4+ cells and a more limited expansion of CD8+CD45RO+ subset, which could be related to the putative lower immunopathogenicity of HIV-2.
一些临床研究表明,HIV - 2感染患者的疾病进展可能比HIV - 1感染患者慢。我们调查了HIV - 1和HIV - 2感染患者之间CD45RO +(记忆性)和CD45RA +(初始性)T细胞亚群的分布是否存在差异。
通过流式细胞术分析健康对照者、HIV - 1感染患者(n = 49)和HIV - 2感染患者(n = 47)外周血单个核细胞中的淋巴细胞亚群。HIV - 1和HIV - 2感染患者又分为两组:无症状(ASY)/持续性全身性淋巴结肿大(PGL)组以及艾滋病相关综合征(ARC)/艾滋病组。
与血清学阴性个体相比,HIV - 1和HIV - 2感染患者的CD4 +淋巴细胞绝对数和百分比均显著降低。处于相同临床阶段的HIV - 2和HIV - 1感染患者之间未发现显著差异。HIV - 1和HIV - 2 ARC/艾滋病患者的CD4 + CD45RA +细胞显著减少,ASY/PGL HIV - 1和HIV - 2患者的该细胞轻度减少。ASY/PGL HIV - 1与HIV - 2患者的CD4 + CD45RO +细胞减少程度无差异。然而,在HIV - 1感染的ARC/艾滋病个体中,该亚群百分比的降低比HIV - 2感染更明显,且这种差异具有统计学意义。HIV - 1感染患者中CD8 +淋巴细胞(百分比和绝对数)的增加更为明显,HIV - 1和HIV - 2感染患者之间的差异具有统计学意义。ASY/PGL和ARC/艾滋病HIV - 1感染患者的CD8 + CD45RO +细胞均显著增加,而HIV - 2感染的ASY/PGL患者这些细胞水平正常,HIV - 2感染的ARC/艾滋病患者的增加程度远低于HIV - 1感染的ARC/艾滋病患者。在相似临床阶段的HIV - 1和HIV - 2感染个体之间,该亚群的绝对数和百分比存在显著差异。
HIV - 2感染个体的记忆性CD4 +细胞耗竭程度较低,CD8 + CD45RO +亚群的扩增更有限,这可能与HIV - 2假定的较低免疫致病性有关。